REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinica Integral Del Sur S.A.S. Zomac (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Clinica Integral Del Sur S.A.S. Zomac Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Clinica Integral Del Sur S.A.S. Zomac is based in Colombia. The head office is in Aguachica. It operates in the General Medical and Surgical Hospitals industry. The company was established on December 09, 2021. From the latest financial highlights, Clinica Integral Del Sur S.A.S. Zomac reported a net sales revenue increase of 115485118266.67% in 2023. A growth of 1232.6% was recorded in its total assets. Clinica Integral Del Sur S.A.S. Zomac’s net profit margin decreased by 27.5% in 2023.

Headquarters
Calle 3 19 - 51
Aguachica; Cesar;

Contact Details: Purchase the Clinica Integral Del Sur S.A.S. Zomac report to view the information.

Basic Information
Outstanding Shares:
Purchase the Clinica Integral Del Sur S.A.S. Zomac report to view the information.
Incorporation Date:
December 09, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Clinica Integral Del Sur S.A.S. Zomac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
115485118266.67%
Total operating revenue
115485118266.67%
Operating profit (EBIT)
36248656600%
Net Profit (Loss) for the Period
20197548800%
Total assets
1232.6%
Total equity
433.15%
Operating Profit Margin (ROS)
-22.87%
Net Profit Margin
-27.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?